Respiratory depression following morphine and morphine-6-glucuronide in normal subjects

British Journal of Clinical Pharmacology

Volumn 40, Issue 2, 1995, Pages 145-152

  Thompson, P I ^a   Joel, S P ^a   John, L ^a   Wedzicha, J A ^a   MacLean, M ^a   Slevin, M L ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Morphine; Morphine 6 glucuronide; Pharmacodynamics; Respiratory depression; Toxicity

Indexed keywords

MORPHINE; MORPHINE 6 GLUCURONIDE;

ADULT; ANALGESIA; ARTICLE; BLOOD GAS; BRADYCARDIA; CARBON DIOXIDE TENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; EXPIRED AIR; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; NOCICEPTION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; THORAX PAIN; VOMITING;

ADULT; ANALGESICS, OPIOID; BLOOD PRESSURE; CARBON DIOXIDE; DEPRESSION, CHEMICAL; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; ISCHEMIA; MALE; MIDDLE AGED; MORPHINE; MORPHINE DERIVATIVES; NAUSEA; PAIN; PARTIAL PRESSURE; RESPIRATION; RESPIRATORY FUNCTION TESTS; VOMITING;

EID: 0029146758     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)